CareNet
3
26M
2
0.11
0.33
- Areas of investment
Summary
In 1996 was created CareNet, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Tokyo. The venture was found in Asia in Japan.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.
We can highlight the next thriving fund investment areas, such as Biotechnology, Life Science. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Modalis Therapeutics For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 6 participants. Despite the CareNet, startups are often financed by SMBC Venture Capital, SBI Investment, Mizuho Capital. The meaningful sponsors for the fund in investment in the same round are UTokyo Innovation Platform, SMBC Venture Capital, SBI Investment.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.11
- Follow on index
- 0.33
- Investments by industry
- Life Science (3)
- Biotechnology (3)
- Health Care (1)
- Therapeutics (1)
- Investments by region
-
- United States (1)
- Japan (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Modalis Therapeutics | 20 Dec 2017 | Biotechnology, Life Science | Early Stage Venture | 4M | Chiyoda, Japan |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.